MZ3 induces apoptosis in human leukemia cells

Cancer Chemotherapy and Pharmacology

Volumn 59, Issue 3, 2007, Pages 397-405

  Fang, Liang ^a   He, Qiaojun ^a   Hu, Yongzhou ^a   Yang, Bo ^a  

^a ZHEJIANG UNIVERSITY   (China)

Author keywords

Bcl 2 protein family; Caspases; Leukemia; MAPKs; Mitochondria

Indexed keywords

4 (4 BROMOPHENYL) 2,3 DIHYDRO N,3 BIS(3,4,5 TRIMETHOXYPHENYL) 2 OXOIMIDAZOLE 1 CARBOXAMIDE; 5 CARBOXY 2',7' DICHLOROFLUORESCIN DIACETATE; 5,5',6,6' TETRACHLORO 1,1',3,3' TETRAETHYLBENZIMIDAZOLE CARBOCYANINE IODIDE; 6 CARBOXY 2',7' DICHLOROFLUORESCIN DIACETATE; ACETOACETIC ACID DERIVATIVE; ACETYLCYSTEINE; ANTINEOPLASTIC AGENT; CARBOCYANINE; CASPASE 3; CYCLOPHOSPHAMIDE; DNA FRAGMENT; IODINE DERIVATIVE; MITOGEN ACTIVATED PROTEIN KINASE; MZ 3; PROTEIN BCL 2; REACTIVE OXYGEN METABOLITE; UNCLASSIFIED DRUG;

AGAR GEL ELECTROPHORESIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CONTROLLED STUDY; CYTOTOXICITY; DISEASE SEVERITY; DRUG MECHANISM; ENGRAFTMENT; ENZYME ACTIVATION; FEMALE; FLOW CYTOMETRY; HUMAN; HUMAN CELL; IMMUNE DEFICIENCY; IN VIVO STUDY; LEUKEMIA; LEUKEMIA CELL LINE; MEMBRANE POTENTIAL; MITOCHONDRIAL MEMBRANE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; SCID MOUSE; STAINING; SURVIVAL TIME; WESTERN BLOTTING;

ANIMALS; ANTINEOPLASTIC AGENTS, PHYTOGENIC; APOPTOSIS; CELL SURVIVAL; DNA FRAGMENTATION; DNA, NEOPLASM; DRUG SCREENING ASSAYS, ANTITUMOR; FORMAZANS; HL-60 CELLS; HUMANS; IMIDAZOLES; K562 CELLS; LEUKEMIA; LONGEVITY; MEMBRANE POTENTIAL, MITOCHONDRIAL; MICE; MICE, SCID; PROTO-ONCOGENE PROTEINS C-BCL-2; REACTIVE OXYGEN SPECIES; STILBENES; TETRAZOLIUM SALTS;

EID: 33845868779     PISSN: 03445704     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00280-006-0294-6     Document Type: Article

References (43)

1. Nam NH (2003) Combretastatin A-4 analogues as antimitotic antitumor agents. Curr Med Chem 10:1697-1722
2. Ohsumi K, Nakagawa R, Fukuda Y et al (1998) Novel combretastatin analogues effective against murine solid tumors, design and structure-activity relationships. J Med Chem 41:3022-3032
3. Cheng Y, Hu Y (2004a) One-pot facile synthesis of 1,3,4-tri-substituted imidazolin-2-ones. J Chem Res 4:292-293
4. Cheng Y, Hu Y (2004b) Synthesis of arylsubstituted imidazolin-2-one analogues. Chin Chem Lett 15:1281-1284
5. Cheng Y, Hu Y, He Q (2005) Synthesis and antitumor activity of arylsubstituted imidazolin-2-one derivatives. Yao Xue Xue Bao 40:711-716
6. Ling YH, Liebes L, Zou Y, Perez-Soler R (2003a) Reactive oxygen species generation and mitochondrial dysfunction in the apoptotic response to Bortezomib, a novel proteasome inhibitor, in human H460 non-small cell lung cancer cells. J Biol Chem 278:33714-33723
7. Ryan L, O'Callaghan YC, O'Brien NM (2005) The role of the mitochondria in apoptosis induced by 7beta-hydroxycholesterol and cholesterol-5beta,6beta- epoxide. Br J Nutr 94:519-525
8. Tang L, Zhang Y (2005a) Mitochondria are the primary target in isothiocyanate-induced apoptosis in human bladder cancer cells. Mol Cancer Ther 4:1250-1259
9. CIP1/WAF1. Cancer Res 63:3637-3645
10. Batra S, Reynolds CP, Maurer BJ (2004) Fenretinide cytotoxicity for Ewing's sarcoma and primitive neuroectodermal tumor cell lines is decreased by hypoxia and synergistically enhanced by ceramide modulators. Cancer Res 64:5415-5424
11. Rotem R, Heyfets A, Fingrut O, Blickstein D, Shaklai M, Flescher E (2005) Jasmonates, novel anticancer agents acting directly and selectively on human cancer cell mitochondria. Cancer Res 65:1984-1993
12. Ogbourne SM, Suhrbier A, Jones B et al (2004) Antitumor activity of 3-ingenyl angelate, plasma membrane and mitochondrial disruption and necrotic cell death. Cancer Res 64:2833-2839
13. Wu CC, Chan ML, Chen WY, Tsai CY, Chang FR, Wu YC (2005) Pristimerin induces caspase-dependent apoptosis in MDA-MB-231 cells via direct effects on mitochondria. Mol Cancer Ther 4:1277-1285
14. Doi S, Soda H, Oka M et al (2004) The histone deacetylase inhibitor FR901228 induces caspase-dependent apoptosis via the mitochondrial pathway in small cell lung cancer cells. Mol Cancer Ther 3:1397-1402
15. Chang L, Karin M (2001) Mammalian MAP kinase signalling cascades. Nature 410:37-40
16. Choi JM, Shin HK, Kim KY, Lee JH, Hong KW (2002) Neuroprotective effect of cilostazol against focal cerebral ischemia via antiapoptotic action in rats. J Pharmacol Exp Ther 300:787-793
17. Ghobrial IM, Witzig TE, Adjei AA (2005) Targeting apoptosis pathways in cancer therapy. CA Cancer J Clin 55:178-194
18. Tang L, Zhang Y (2005b) Mitochondria are the primary target in isothiocyanate-induced apoptosis in human bladder cancer cells. Mol Cancer Ther 4:1250-1259
19. Oliver CL, Miranda MB, Shangary S, Land S, Wang S, Johnson DE (2005) (-)-Gossypol acts directly on the mitochondria to overcome Bcl-2- and Bcl-X(L)-mediated apoptosis resistance. Mol Cancer Ther 4:23-31
20. Miao ZH, Ding J (2003) Transcription factor c-Jun activation represses mdr-1 gene expression. Cancer Res 63:4527-4532
21. Yang B, Reynolds CP (2005) Tirapazamine cytotoxicity for neuroblastoma is p53 dependent. Clin Cancer Res 11:2774-2780
22. Zhou L, Zhu X (2000) Reactive oxygen species-induced apoptosis in PC12 cells and protective effect of bilobalide. J Pharmacol Exp Ther 293:982-988
23. Ling Y, Liebes L, Zou Y, Perez-Soler R (2003b) Reactive oxygen species generation and mitochondrial dysfunction in the apoptotic response to Bortezomib, a novel proteasome inhibitor, in human H460 non-small cell lung cancer cells. J Biol Chem 278:33714-33723
24. Ratajczak MZ, Kant JA, Luger SM et al (1992) In vivo treatment of human leukemia in a scid mouse model with c-myb antisense oligodeoxynucleotides. Proc Natl Acad Sci USA 89:11823-11827
25. Naumovski L, Ramos J, Sirisawad M et al (2005a) Sapphyrins induce apoptosis in hematopoietic tumor-derived cell lines and show in vivo antitumor activity. Mol Cancer Ther 4:968-976
26. Devi GR (2004) XIAP as target for therapeutic apoptosis in prostate cancer. Drug News Perspect 17:127-134
27. Naumovski L, Ramos J, Sirisawad M et al (2005b) Sapphyrins induce apoptosis in hematopoietic tumor-derived cell lines and show in vivo antitumor activity. Mol Cancer Ther 4:968-976
28. Amantana A, London CA, Iversen PL, Devi GR (2004) X-linked inhibitor of apoptosis protein inhibition induces apoptosis and enhances chemotherapy sensitivity in human prostate cancer cells. Mol Cancer Ther 3:699-707
29. Yamanaka K, Rocchi P, Miyake H et al (2005) A novel antisense oligonucleotide inhibiting several antiapoptotic Bcl-2 family members induces apoptosis and enhances chemosensitivity in androgen-independent human prostate cancer PC3 cells. Mol Cancer Ther 4:1689-1698
30. Sinicrope FA, Penington RC (2005) Sulindac sulfide-induced apoptosis is enhanced by a small-molecule Bcl-2 inhibitor and by TRAIL in human colon cancer cells overexpressing Bcl-2. Mol Cancer Ther 4:1475-1483
31. Hayward RL, Macpherson JS, Cummings J, Monia BP, Smyth JF, Jodrell DI (2004) Enhanced oxaliplatin-induced apoptosis following antisense Bcl-xl down-regulation is p53 and Bax dependent, genetic evidence for specificity of the antisense effect. Mol Cancer Ther 3:169-178
32. Katiyar SK, Roy AM, Baliga MS (2005) Silymarin induces apoptosis primarily through a p53-dependent pathway involving Bcl-2/Bax, cytochrome c release, and caspase activation. Mol Cancer Ther 4:207-216
33. Childs AC, Phaneuf SL, Dirks AJ, Phillips T, Leeuwenburgh C (2002) Doxorubicin treatment in vivo causes cytochrome C release and cardiomyocyte apoptosis, as well as increased mitochondrial efficiency, superoxide dismutase activity, and Bcl-2, Bax ratio. Cancer Res 62:4592-4598
34. Cobb MH (1999) MAP kinase pathways. Prog Biophys Mol Biol 71:479-500
35. Xia Z, Dickens M, Raingeaud J, Davis RJ, Greenberg ME (1995) Opposing effects of ERK and JNK-p38 MAP kinases on apoptosis. Science 270:1326-1331
36. Ortiz MA, Lopez-Hernandez FJ, Bayon Y, Pfahl M, Piedrafita FJ (2001) Retinoid-related molecules induce cytochrome c release and apoptosis through activation of c-Jun NH(2)-terminal kinase/p38 mitogen-activated protein kinases. Cancer Res 61:8504-8512
37. Miyoshi N, Uchida K, Osawa T, Nakamura Y (2004) A link between benzyl isothiocyanate-induced cell cycle arrest and apoptosis, involvement of mitogen-activated protein kinases in the Bcl-2 phosphorylation. Cancer Res 64:2134-2142
38. Lewis TS, Shapiro PS, Ahn NG (1998) Signal transduction through MAP kinase cascades. Adv Cancer Res 74:49-139
39. Rice PL, Washington M, Schleman S, Beard KS, Driggers LJ, Ahnen DJ (2003) Sulindac sulfide inhibits epidermal growth factor-induced phosphorylation of extracellular-regulated kinase 1/2 and Bad in human colon cancer cells. Cancer Res 63:616-620
40. Liu YZ, Boxer LM, Latchman DS (1999) Activation of the Bcl-2 promoter by nerve growth factor is mediated by the p42/p44 MAPK cascade. Nucleic Acids Res 27:2086-2090
41. Jost M, Huggett TM, Kari C, Boise LH, Rodeck U (2001) Epidermal growth factor receptor-dependent control of keratinocyte survival and Bcl-xL expression through a MEK-dependent pathway. J Biol Chem 276:6320-6326
42. Capano M, Crompton M (2006) Bax translocates to mitochondria of heart cells during simulated ischaemia, involvement of AMP-activated and p38 mitogen-activated protein kinases. Biochem J 395:57-64
43. Van Laethem A, Van Kelst S, Lippens S et al (2004) Activation of p38 MAPK is required for Bax translocation to mitochondria, cytochrome c release and apoptosis induced by UVB irradiation in human keratinocytes. FASEB J 18:1946-1948